Joseph F. Goldberg, MD

Joseph Goldberg, MD, discusses the recent joint statement on evidence-based medicine and psychotropic safety.

Joseph F. Goldberg, MD, gives a preview of his upcoming panel presentation at the 2024 ASCP Annual Meeting.

Joseph F. Goldberg, MD, sat down with Psychiatric Times' Editor-in-Chief at the 2024 APA Annual Meeting.

What are the key differences?

Tips to tailoring treatment of mood disorders using a measured approach.

Baseline factors that can influence treatment outcomes in psychiatric treatment.

The author discusses evidence-based treatment, highlighting clinical trials that support specific uses and patterns of efficacy.

Recent findings suggest that the magnitude of efficacy for most antidepressants compared with placebo may be more modest than previously thought.